Detalhe da pesquisa
1.
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.
Infect Immun
; 92(3): e0022323, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323817
2.
Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats.
Infect Immun
; 89(12): e0034621, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516235
3.
Reinvestigating the Coughing Rat Model of Pertussis To Understand Bordetella pertussis Pathogenesis.
Infect Immun
; 89(12): e0030421, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34125597
4.
Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
Infect Immun
; 89(3)2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33318136
5.
Erratum for Wolf et al., "Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice".
Infect Immun
; 89(10): e0028521, 2021 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34528854
6.
Protocol for aerosolization challenge of mice with Bordetella pertussis.
STAR Protoc
; 4(1): 101979, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598856
7.
Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge.
PLoS One
; 18(11): e0286925, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37917623
8.
CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice.
Vaccine
; 40(35): 5229-5240, 2022 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35927132
9.
Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospital.
medRxiv
; 2021 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426815